RXL — PROSHARES ULTRA HEALTH CARE
As of Q2 2026, 3 SEC-registered investment managers reported holding RXL (PROSHARES ULTRA HEALTH CARE) in their latest 13F filings, with a combined reported value of $492.24K across 9.28K shares. That is +12.6% by share count (+1.04K shares) versus the previous quarter, while reported value moved +30.4%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes, 1 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 9.27K | $492.08K | 0.00% | Add |
| Morgan Stanley history | 1 | $89 | 0.00% | Reduce |
| Wells Fargo & Co history | 1 | $75 | 0.00% | Hold |
Q1 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 8.23K | $377.39K | 0.00% | Add |
| Morgan Stanley history | 2 | $101 | 0.00% | Add |
| Wells Fargo & Co history | 1 | $61 | 0.00% | New |
Q4 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 7.71K | $399.45K | 0.00% | Add |
| Bank of America Corp history | 3.51K | $181.75K | 0.00% | Hold |
| UBS Group AG history | 161 | $8.34K | 0.00% | Reduce |
| Morgan Stanley history | 1 | $86 | 0.00% | New |
Q3 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 7.27K | $309.05K | 0.00% | Reduce |
| Bank of America Corp history | 3.51K | $149.17K | 0.00% | Hold |
| UBS Group AG history | 172 | $7.31K | 0.00% | Reduce |
| Wells Fargo & Co history | 1 | $33 | 0.00% | Hold |
Q2 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Northern Trust Corp history | 13.00K | $528.36K | 0.00% | New |
| Citadel Advisors history | 9.26K | $376.20K | 0.00% | Add |
| Bank of America Corp history | 3.51K | $142.53K | 0.00% | Hold |
| UBS Group AG history | 360 | $14.63K | 0.00% | New |
| Morgan Stanley history | 123 | $5.00K | 0.00% | Add |
| Wells Fargo & Co history | 1 | $23 | 0.00% | Hold |
Q1 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 8.00K | $388.63K | 0.00% | Add |
| Bank of America Corp history | 3.51K | $170.35K | 0.00% | Hold |
| Morgan Stanley history | 69 | $3.40K | 0.00% | Add |
| Wells Fargo & Co history | 1 | $41 | 0.00% | Hold |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 9 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | 9.27K | 8.23K | 7.71K | 7.27K | 9.26K | 8.00K | 4.76K | 3.76K | — | 4.11K | — | 8.51K | 5.39K | 13.44K | 10.26K | 19.77K | 10.86K | — | — | 15.64K |
| Morgan Stanley | 1 | 2 | 1 | — | 123 | 69 | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Wells Fargo & Co | 1 | 1 | — | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | — | — | — | 1 | 1 | 2 | 2 | 1 | 1 |
| Bank of America Corp | — | — | 3.51K | 3.51K | 3.51K | 3.51K | 3.51K | 1.75K | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | — | — | 161 | 172 | 360 | — | 83 | 689 | 15 | — | 244 | — | — | — | — | 821 | 1 | — | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | — | — | — | 1 | — | — | — | — | 1 | 1 | — | 1 |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | 458 | — | — | — | — | — | 20 |
| Citigroup Inc | — | — | — | — | — | — | — | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 360 |
| Northern Trust Corp | — | — | — | — | 13.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details